Novo Nordisk's (NVO) Phase IIIb Study Meets Primary Endpoint

Original post

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Novo Nordisk AS (NVO): Free Stock Analysis Report
 
Alimera Sciences, Inc. (ALIM): Free Stock Analysis Report
 
Abeona Therapeutics Inc. (ABEO): Free Stock Analysis Report
 
ASLAN Pharmaceuticals Ltd. (ASLN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research